Back to Journals » Drug Design, Development and Therapy » Volume 15

Hearing Protection Outcomes of Analog Electrode Arrays Coated with Different Drug-Eluting Polymer Films Implanted into Guinea Pig Cochleae [Corrigendum]

Authors Huang Y, Yu H, Liang M, Hou S, Chen JM, Zhang F, Sun X, Jia H, Yang J

Received 16 November 2021

Accepted for publication 16 November 2021

Published 24 November 2021 Volume 2021:15 Pages 4759—4760

DOI https://doi.org/10.2147/DDDT.S349645



Huang Y, Yu H, Liang M, et al. Drug Des Devel Ther. 2021;15:3443–3450.

The authors have advised the captions for Figures 4–6 on pages 3447-3449, respectively were published in the wrong order. The correct captions are as follows.

Figure 4 The effects of DXM, Ara-C and NAD+ on hair cells: (A) Positive control group (B) DXM group (C) Ara-C group (D) DXM+Ara-C group (E) NAD+ group. No significant difference was detected in OHC or IHC number among groups. Hair cells are stained with phalloidin (red).

Figure 5 The effects of DXM, Ara-C and NAD+ on stria vascularis: (A) Positive control group (B) DXM group (C) Ara-C group (D) DXM+Ara-C group (E) NAD+ group. No significant difference was observed among groups. Stria vascularis are stained with phalloidin (red) and DAPI (blue).

Figure 6 Effects of DXM, Ara-C, NAD+ on the survival of spiral ganglion neurons (SGNs): (A) Positive control group (B) DXM group (C) Ara-C group (D) DXM+Ara-C group (E) NAD+ group (F) Average of the SGN density in each cochlear region after 90 days of different groups. There was a significantly greater density of SGNs in DXM and/or Ara-C group compared to the control, but no significant difference was detected between NAD+ group and control group. SGNs are stained with a neuronal marker (NF200: green) and a nucleus marker (DAPI: blue). (**p < 0.01).

The authors apologize for this oversight and advise it does not affect the results of the paper.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.